Global Shingles Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Shingles Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Shingles Vaccine industry chain, the market status of Under 50 Years Old (Zostavax, Shingrix), 50-60 Years Old (Zostavax, Shingrix), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Shingles Vaccine.
Regionally, the report analyzes the Shingles Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Shingles Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Shingles Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Shingles Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Zostavax, Shingrix).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Shingles Vaccine market.
Regional Analysis: The report involves examining the Shingles Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Shingles Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Shingles Vaccine:
Company Analysis: Report covers individual Shingles Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Shingles Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Under 50 Years Old, 50-60 Years Old).
Technology Analysis: Report covers specific technologies relevant to Shingles Vaccine. It assesses the current state, advancements, and potential future developments in Shingles Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Shingles Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Shingles Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Shingles Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Shingles Vaccine, with price, sales, revenue and global market share of Shingles Vaccine from 2019 to 2024.
Chapter 3, the Shingles Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Shingles Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Shingles Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Shingles Vaccine.
Chapter 14 and 15, to describe Shingles Vaccine sales channel, distributors, customers, research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Shingles Vaccine industry chain, the market status of Under 50 Years Old (Zostavax, Shingrix), 50-60 Years Old (Zostavax, Shingrix), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Shingles Vaccine.
Regionally, the report analyzes the Shingles Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Shingles Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Shingles Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Shingles Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Zostavax, Shingrix).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Shingles Vaccine market.
Regional Analysis: The report involves examining the Shingles Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Shingles Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Shingles Vaccine:
Company Analysis: Report covers individual Shingles Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Shingles Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Under 50 Years Old, 50-60 Years Old).
Technology Analysis: Report covers specific technologies relevant to Shingles Vaccine. It assesses the current state, advancements, and potential future developments in Shingles Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Shingles Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Shingles Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Zostavax
- Shingrix
- Under 50 Years Old
- 50-60 Years Old
- 60-70 Years Old
- Above 70 Years Old
- Merck
- GlaxoSmithKline
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Shingles Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Shingles Vaccine, with price, sales, revenue and global market share of Shingles Vaccine from 2019 to 2024.
Chapter 3, the Shingles Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Shingles Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Shingles Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Shingles Vaccine.
Chapter 14 and 15, to describe Shingles Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Shingles Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Shingles Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Zostavax
1.3.3 Shingrix
1.4 Market Analysis by Application
1.4.1 Overview: Global Shingles Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Under 50 Years Old
1.4.3 50-60 Years Old
1.4.4 60-70 Years Old
1.4.5 Above 70 Years Old
1.5 Global Shingles Vaccine Market Size & Forecast
1.5.1 Global Shingles Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Shingles Vaccine Sales Quantity (2019-2030)
1.5.3 Global Shingles Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Shingles Vaccine Product and Services
2.1.4 Merck Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Shingles Vaccine Product and Services
2.2.4 GlaxoSmithKline Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GlaxoSmithKline Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SHINGLES VACCINE BY MANUFACTURER
3.1 Global Shingles Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Shingles Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Shingles Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Shingles Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Shingles Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Shingles Vaccine Manufacturer Market Share in 2023
3.5 Shingles Vaccine Market: Overall Company Footprint Analysis
3.5.1 Shingles Vaccine Market: Region Footprint
3.5.2 Shingles Vaccine Market: Company Product Type Footprint
3.5.3 Shingles Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Shingles Vaccine Market Size by Region
4.1.1 Global Shingles Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Shingles Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Shingles Vaccine Average Price by Region (2019-2030)
4.2 North America Shingles Vaccine Consumption Value (2019-2030)
4.3 Europe Shingles Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Shingles Vaccine Consumption Value (2019-2030)
4.5 South America Shingles Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Shingles Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Shingles Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Shingles Vaccine Consumption Value by Type (2019-2030)
5.3 Global Shingles Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Shingles Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Shingles Vaccine Consumption Value by Application (2019-2030)
6.3 Global Shingles Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Shingles Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Shingles Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Shingles Vaccine Market Size by Country
7.3.1 North America Shingles Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Shingles Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Shingles Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Shingles Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Shingles Vaccine Market Size by Country
8.3.1 Europe Shingles Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Shingles Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Shingles Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Shingles Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Shingles Vaccine Market Size by Region
9.3.1 Asia-Pacific Shingles Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Shingles Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Shingles Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Shingles Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Shingles Vaccine Market Size by Country
10.3.1 South America Shingles Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Shingles Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Shingles Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Shingles Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Shingles Vaccine Market Size by Country
11.3.1 Middle East & Africa Shingles Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Shingles Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Shingles Vaccine Market Drivers
12.2 Shingles Vaccine Market Restraints
12.3 Shingles Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Shingles Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Shingles Vaccine
13.3 Shingles Vaccine Production Process
13.4 Shingles Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Shingles Vaccine Typical Distributors
14.3 Shingles Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Shingles Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Shingles Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Zostavax
1.3.3 Shingrix
1.4 Market Analysis by Application
1.4.1 Overview: Global Shingles Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Under 50 Years Old
1.4.3 50-60 Years Old
1.4.4 60-70 Years Old
1.4.5 Above 70 Years Old
1.5 Global Shingles Vaccine Market Size & Forecast
1.5.1 Global Shingles Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Shingles Vaccine Sales Quantity (2019-2030)
1.5.3 Global Shingles Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Shingles Vaccine Product and Services
2.1.4 Merck Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Shingles Vaccine Product and Services
2.2.4 GlaxoSmithKline Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GlaxoSmithKline Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SHINGLES VACCINE BY MANUFACTURER
3.1 Global Shingles Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Shingles Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Shingles Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Shingles Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Shingles Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Shingles Vaccine Manufacturer Market Share in 2023
3.5 Shingles Vaccine Market: Overall Company Footprint Analysis
3.5.1 Shingles Vaccine Market: Region Footprint
3.5.2 Shingles Vaccine Market: Company Product Type Footprint
3.5.3 Shingles Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Shingles Vaccine Market Size by Region
4.1.1 Global Shingles Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Shingles Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Shingles Vaccine Average Price by Region (2019-2030)
4.2 North America Shingles Vaccine Consumption Value (2019-2030)
4.3 Europe Shingles Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Shingles Vaccine Consumption Value (2019-2030)
4.5 South America Shingles Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Shingles Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Shingles Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Shingles Vaccine Consumption Value by Type (2019-2030)
5.3 Global Shingles Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Shingles Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Shingles Vaccine Consumption Value by Application (2019-2030)
6.3 Global Shingles Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Shingles Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Shingles Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Shingles Vaccine Market Size by Country
7.3.1 North America Shingles Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Shingles Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Shingles Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Shingles Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Shingles Vaccine Market Size by Country
8.3.1 Europe Shingles Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Shingles Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Shingles Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Shingles Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Shingles Vaccine Market Size by Region
9.3.1 Asia-Pacific Shingles Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Shingles Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Shingles Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Shingles Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Shingles Vaccine Market Size by Country
10.3.1 South America Shingles Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Shingles Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Shingles Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Shingles Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Shingles Vaccine Market Size by Country
11.3.1 Middle East & Africa Shingles Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Shingles Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Shingles Vaccine Market Drivers
12.2 Shingles Vaccine Market Restraints
12.3 Shingles Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Shingles Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Shingles Vaccine
13.3 Shingles Vaccine Production Process
13.4 Shingles Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Shingles Vaccine Typical Distributors
14.3 Shingles Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Shingles Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Shingles Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Shingles Vaccine Product and Services
Table 6. Merck Shingles Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Major Business
Table 10. GlaxoSmithKline Shingles Vaccine Product and Services
Table 11. GlaxoSmithKline Shingles Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GlaxoSmithKline Recent Developments/Updates
Table 13. Global Shingles Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 14. Global Shingles Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 15. Global Shingles Vaccine Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 16. Market Position of Manufacturers in Shingles Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 17. Head Office and Shingles Vaccine Production Site of Key Manufacturer
Table 18. Shingles Vaccine Market: Company Product Type Footprint
Table 19. Shingles Vaccine Market: Company Product Application Footprint
Table 20. Shingles Vaccine New Market Entrants and Barriers to Market Entry
Table 21. Shingles Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 22. Global Shingles Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 23. Global Shingles Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 24. Global Shingles Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 25. Global Shingles Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 26. Global Shingles Vaccine Average Price by Region (2019-2024) & (USD/Dose)
Table 27. Global Shingles Vaccine Average Price by Region (2025-2030) & (USD/Dose)
Table 28. Global Shingles Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 29. Global Shingles Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 30. Global Shingles Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 31. Global Shingles Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 32. Global Shingles Vaccine Average Price by Type (2019-2024) & (USD/Dose)
Table 33. Global Shingles Vaccine Average Price by Type (2025-2030) & (USD/Dose)
Table 34. Global Shingles Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 35. Global Shingles Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 36. Global Shingles Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 37. Global Shingles Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 38. Global Shingles Vaccine Average Price by Application (2019-2024) & (USD/Dose)
Table 39. Global Shingles Vaccine Average Price by Application (2025-2030) & (USD/Dose)
Table 40. North America Shingles Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 41. North America Shingles Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 42. North America Shingles Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 43. North America Shingles Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 44. North America Shingles Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 45. North America Shingles Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 46. North America Shingles Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 47. North America Shingles Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 48. Europe Shingles Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 49. Europe Shingles Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 50. Europe Shingles Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 51. Europe Shingles Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 52. Europe Shingles Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 53. Europe Shingles Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 54. Europe Shingles Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 55. Europe Shingles Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 56. Asia-Pacific Shingles Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 57. Asia-Pacific Shingles Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 58. Asia-Pacific Shingles Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 59. Asia-Pacific Shingles Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 60. Asia-Pacific Shingles Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 61. Asia-Pacific Shingles Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 62. Asia-Pacific Shingles Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 63. Asia-Pacific Shingles Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 64. South America Shingles Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 65. South America Shingles Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 66. South America Shingles Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 67. South America Shingles Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 68. South America Shingles Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 69. South America Shingles Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 70. South America Shingles Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 71. South America Shingles Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 72. Middle East & Africa Shingles Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 73. Middle East & Africa Shingles Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 74. Middle East & Africa Shingles Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 75. Middle East & Africa Shingles Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 76. Middle East & Africa Shingles Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 77. Middle East & Africa Shingles Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 78. Middle East & Africa Shingles Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 79. Middle East & Africa Shingles Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 80. Shingles Vaccine Raw Material
Table 81. Key Manufacturers of Shingles Vaccine Raw Materials
Table 82. Shingles Vaccine Typical Distributors
Table 83. Shingles Vaccine Typical Customers
Table 1. Global Shingles Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Shingles Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Shingles Vaccine Product and Services
Table 6. Merck Shingles Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Major Business
Table 10. GlaxoSmithKline Shingles Vaccine Product and Services
Table 11. GlaxoSmithKline Shingles Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GlaxoSmithKline Recent Developments/Updates
Table 13. Global Shingles Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 14. Global Shingles Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 15. Global Shingles Vaccine Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 16. Market Position of Manufacturers in Shingles Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 17. Head Office and Shingles Vaccine Production Site of Key Manufacturer
Table 18. Shingles Vaccine Market: Company Product Type Footprint
Table 19. Shingles Vaccine Market: Company Product Application Footprint
Table 20. Shingles Vaccine New Market Entrants and Barriers to Market Entry
Table 21. Shingles Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 22. Global Shingles Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 23. Global Shingles Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 24. Global Shingles Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 25. Global Shingles Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 26. Global Shingles Vaccine Average Price by Region (2019-2024) & (USD/Dose)
Table 27. Global Shingles Vaccine Average Price by Region (2025-2030) & (USD/Dose)
Table 28. Global Shingles Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 29. Global Shingles Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 30. Global Shingles Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 31. Global Shingles Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 32. Global Shingles Vaccine Average Price by Type (2019-2024) & (USD/Dose)
Table 33. Global Shingles Vaccine Average Price by Type (2025-2030) & (USD/Dose)
Table 34. Global Shingles Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 35. Global Shingles Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 36. Global Shingles Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 37. Global Shingles Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 38. Global Shingles Vaccine Average Price by Application (2019-2024) & (USD/Dose)
Table 39. Global Shingles Vaccine Average Price by Application (2025-2030) & (USD/Dose)
Table 40. North America Shingles Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 41. North America Shingles Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 42. North America Shingles Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 43. North America Shingles Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 44. North America Shingles Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 45. North America Shingles Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 46. North America Shingles Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 47. North America Shingles Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 48. Europe Shingles Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 49. Europe Shingles Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 50. Europe Shingles Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 51. Europe Shingles Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 52. Europe Shingles Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 53. Europe Shingles Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 54. Europe Shingles Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 55. Europe Shingles Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 56. Asia-Pacific Shingles Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 57. Asia-Pacific Shingles Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 58. Asia-Pacific Shingles Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 59. Asia-Pacific Shingles Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 60. Asia-Pacific Shingles Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 61. Asia-Pacific Shingles Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 62. Asia-Pacific Shingles Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 63. Asia-Pacific Shingles Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 64. South America Shingles Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 65. South America Shingles Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 66. South America Shingles Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 67. South America Shingles Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 68. South America Shingles Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 69. South America Shingles Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 70. South America Shingles Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 71. South America Shingles Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 72. Middle East & Africa Shingles Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 73. Middle East & Africa Shingles Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 74. Middle East & Africa Shingles Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 75. Middle East & Africa Shingles Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 76. Middle East & Africa Shingles Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 77. Middle East & Africa Shingles Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 78. Middle East & Africa Shingles Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 79. Middle East & Africa Shingles Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 80. Shingles Vaccine Raw Material
Table 81. Key Manufacturers of Shingles Vaccine Raw Materials
Table 82. Shingles Vaccine Typical Distributors
Table 83. Shingles Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Shingles Vaccine Picture
Figure 2. Global Shingles Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Shingles Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Zostavax Examples
Figure 5. Shingrix Examples
Figure 6. Global Shingles Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Shingles Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Under 50 Years Old Examples
Figure 9. 50-60 Years Old Examples
Figure 10. 60-70 Years Old Examples
Figure 11. Above 70 Years Old Examples
Figure 12. Global Shingles Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Shingles Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Shingles Vaccine Sales Quantity (2019-2030) & (K Doses)
Figure 15. Global Shingles Vaccine Average Price (2019-2030) & (USD/Dose)
Figure 16. Global Shingles Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Shingles Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Shingles Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Shingles Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Shingles Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Shingles Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Shingles Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Shingles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Shingles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Shingles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Shingles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Shingles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Shingles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Shingles Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Shingles Vaccine Average Price by Type (2019-2030) & (USD/Dose)
Figure 31. Global Shingles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Shingles Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Shingles Vaccine Average Price by Application (2019-2030) & (USD/Dose)
Figure 34. North America Shingles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Shingles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Shingles Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Shingles Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Shingles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Shingles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Shingles Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Shingles Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Shingles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Shingles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Shingles Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Shingles Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Shingles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Shingles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Shingles Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Shingles Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Shingles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Shingles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Shingles Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Shingles Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Shingles Vaccine Market Drivers
Figure 75. Shingles Vaccine Market Restraints
Figure 76. Shingles Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Shingles Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Shingles Vaccine
Figure 80. Shingles Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Shingles Vaccine Picture
Figure 2. Global Shingles Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Shingles Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Zostavax Examples
Figure 5. Shingrix Examples
Figure 6. Global Shingles Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Shingles Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Under 50 Years Old Examples
Figure 9. 50-60 Years Old Examples
Figure 10. 60-70 Years Old Examples
Figure 11. Above 70 Years Old Examples
Figure 12. Global Shingles Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Shingles Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Shingles Vaccine Sales Quantity (2019-2030) & (K Doses)
Figure 15. Global Shingles Vaccine Average Price (2019-2030) & (USD/Dose)
Figure 16. Global Shingles Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Shingles Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Shingles Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Shingles Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Shingles Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Shingles Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Shingles Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Shingles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Shingles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Shingles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Shingles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Shingles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Shingles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Shingles Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Shingles Vaccine Average Price by Type (2019-2030) & (USD/Dose)
Figure 31. Global Shingles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Shingles Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Shingles Vaccine Average Price by Application (2019-2030) & (USD/Dose)
Figure 34. North America Shingles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Shingles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Shingles Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Shingles Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Shingles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Shingles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Shingles Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Shingles Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Shingles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Shingles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Shingles Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Shingles Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Shingles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Shingles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Shingles Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Shingles Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Shingles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Shingles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Shingles Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Shingles Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Shingles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Shingles Vaccine Market Drivers
Figure 75. Shingles Vaccine Market Restraints
Figure 76. Shingles Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Shingles Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Shingles Vaccine
Figure 80. Shingles Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
